Blog

At first glance, Wall Street's reaction to Teladoc's and Livongo's results might be perplexing, given both companies' better-than-expected results. This suggests that the stock has a possible downside of 20.6%. So what's going on with these two healthcare disrupters? Livongo Health has generated ($1.01) earnings per share over the last year. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. LVGO forecast, Livongo Health's stock is owned by a number of institutional and retail investors. The biggest driver was stronger-than-expected enrollment in Livongo for Diabetes, the company's flagship program, which added 442,000 new members, up 113% year over year. Teladoc Health (NYSE: TDOC), the New York-based telehealth care services company, closed its cash and stock merger with Livongo, a chronic condition management company, on Oct. 30.Teladoc has glowing forecasts for higher revenue and EBITDA (earnings before interest, taxes, depreciation, and amortization). ... Teladoc bets big on online medicine with $18.5 billion Livongo deal By Reuters - Aug 05, 2020. The problem is TDOC stock already more than reflects the benefits of the merger and … Teladoc's stock price and forecast On Oct. 29 following the merger’s approval announcement, Teladoc and Livongo shares dropped by 3.9 percent. Revenues in 2020 of $1.339 billion (on a pro forma … So Why Are Their Stocks Down? LVGO - Livongo Health Basic Chart, Quote and financial news from the leading provider and award-winning BigCharts.com. Livongo Health, Inc. is expected* to report earnings on 05/06/2020 after market close. 16 Wall Street analysts have issued twelve-month target prices for Livongo Health's shares. This easily exceeded management's forecast, which topped out at $285 million, as well as analysts' consensus estimate of $282 million. Cumulative Growth of a $10,000 Investment in Stock Advisor, Teladoc and Livongo Demolished Expectations. Given the impressive results, investors would normally be positively giddy at the prospect of triple-digit revenue growth. 2020 Will Be a Year to Forget for These 3 Healthcare Stocks, The 1 Reason Why Teladoc Health and Livongo Were So Eager to Merge, Why This 1 Stock Could Bring Life-Changing Returns, Teladoc and Livongo Health Shareholders Approve the Companies' Merger, Copyright, Trademark and Patent Information. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the LVGO stock to lose ahead of the earnings release. Livongo Health, Inc. (LVGO) estimates and forecasts. Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. Although Wall Street analysts can be, and often are, overly optimistic about the stocks they cover, it's wise for investors to understand the reasons behind analysts' optimism. Its total client base also swelled, up 71% to 1,402. This easily topped analysts' consensus estimate of $95.6 million. Figures show that Livongo Health, Inc. shares have underperformed across the wider relevant industry. Livongo has a market cap of $12.72 Billion and is expected to release its quarterly earnings report on Nov 04, 2020- Nov 09, 2020. Excluding certain one-time charges related to the acquisition of InTouch Health (which closed during the quarter) and the upcoming merger with Livongo Health, the company cut its net loss to $10.7 million, much improved from $20.3 million in the prior-year quarter. Stock Advisor launched in February of 2002. Livongo Health does not currently pay a dividend. Close price at the end of the last trading day (Friday, 4th Dec 2020) of the LVGO stock was … But it's important to consider the context of each stock's performance year-to-date. Livongo Health, Inc. () Stock Market info Recommendations: Buy or sell Livongo Health stock? Fiscal Period: December 2019: 2020: 2021: Capitalization 1: 2 368: 14 199-Entreprise Value (EV) 1 1 976: 13 905: 13 953: P/E ratio-23,2x--Yield---Capitalization / Revenue: 13,9x In the short term (2weeks), LVGO's stock price should underperform the market by -1.48%.During that period the price should oscillate between -9.63% and +8.16%.. Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Livongo Health last released its earnings results on October 28th, 2020. That optimism could be well-founded. At that level they are trading … So Why Are Their Stocks Down? Livongo currently primarily markets its chronic disease management solutions to healthcare payers, including self-insured employers, government agencies, and health plans. He served on active duty with the US Army and has a Bachelor's degree in accounting. Their forecasts range from $46.00 to $170.00. From the statistics provided in Cowen’s survey from August 20th, 2020, back in October 2019, only 51% of employers surveyed offered telehealth benefits. Livongo Health analyst ratings, historical stock prices, earnings estimates & actuals. There are currently 5 hold ratings and 12 buy ratings for the stock, resulting in a consensus rating of "Buy.". Teladoc had already climbed 171% so far in 2020, while Livongo stock had soared 480% leading up to their respective earnings reports, even as the S&P 500 was essentially flat. Two of the most high-profile healthcare stocks of 2020, Teladoc Health (NYSE:TDOC) and Livongo Health (NASDAQ:LVGO), reported third-quarter earnings after the market close last Wednesday. Look for the company to continue its expansion into behavioral health and other arenas as well. See you at the top! Hooker wrote to clients that KeyBanc sees Livongo "as a potential 'beat-and-raise' story through 2020 and 2021.". According to Zacks Investment Research, based on 1 analysts’ forecasts, the consensus EPS forecast for the quarter is $-0.1. Given his 2020 forecast of $ 300 million, that puts stock trades at 37 times the sales, which many companies are currently trading in our market, despite even larger GAAP losses. Market data powered by FactSet and Web Financial Group. Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. Livongo Health (NASDAQ:LVGO) Earnings Information. Copyright, Trademark and Patent Information. No changes to the price of Livongo Health Inc. stock on the last trading day (Friday, 11th Dec 2020). Skip to main navigation ... Livongo Reports Third Quarter 2020 Financial Results. Information about the Livongo Health Inc Stock. Livongo Health also reported stellar results. Livongo stock has doubled in last 7 weeks — here’s why. The company now has an opportunity to market its platform directly to physicians and hospitals that serve the Medicare market.Â. Returns as of 12/15/2020. This marked an acceleration from 41% revenue growth in Q1 and 85% in Q2. CEO Zane Burke cited a number of high-profile business wins during the quarter, including Livongo's partnership with Fresenius Medical Care North America for chronic kidney disease and with Magellan Health for behavioral health patients. The reported $0.16 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.05 by $0.11. Teladoc reported revenue of $289 million, up 109% year over year. Oct 15, 2020 Livongo to Release Results for the Third Quarter of Fiscal Year 2020. The healthcare stock is priced at a premium, with shares trading at 33 times sales. Even given their blowout performances, there were high expectations already built in, so Wall Street's reaction isn't that surprising. by | Oct 17, 2020 | Uncategorized | | Oct 17, 2020 | Uncategorized | Livongo Health, Inc. Stock Price Forecast, "LVGO" Predictons for2021 Third-quarter revenue climbed to $106.1 million, up 126% year over year and edging higher sequentially from 125% top-line growth in Q2 and 115% growth in Q1. Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. Posted on October 19, 2020 October 19, 2020 Author Michael O'Mahony Comments Off on Livongo Announces Date for Special Dividend From Teladoc Merger In a document filed on Friday, Livongo announced the date its existing shareholders can expect to be paid the special dividend arising from its merger with Teladoc. Let's conquer your financial goals together...faster. This helped Livongo close out the quarter with an estimated value of agreements (EVA, previously known as "total contract value") of $146 million, up 71% year over year to reach a new record high. * Third quarter total revenue of $106.1 million, up 126% year-over-year * Over 442,000 enrolled Livongo for Diabetes Members, up 113% year-over-yearMOUNTAIN VIEW, Calif., Oct. 28, 2020 … Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services. Do you know rising stars in Silicon Valley? But Livongo's opportunities appear to justify its lofty valuation. Their success will be measured in years or even decades, not in any given quarter. Up 143% in 2020, Is Teladoc Health Still a Buy? @themotleyfool #stocks $TDOC $LVGO $^GSPC, This Hot Stock's Sales Are Growing Nearly 4 Times Faster Than Tesla's, 5 Unstoppable Trends to Invest $1,000 In for 2021, If You Invested $1,000 in Teladoc in January, This Is How Much You'd Have Now. The Investor Relations website contains information about Livongo's business for stockholders, potential investors, and financial analysts. That said, despite all the enthusiasm for the title, as next year approaches, Livongo’s revenue growth rates are expected to slow: Source: SA Premium Tools livongo stock forecast. Shares of Livongo Health (NASDAQ:LVGO) jumped 6.4% higher on Monday, after KeyBanc analyst Donald Hooker raised his price target on the stock to $85 from $52. Livongo Health, Inc. (NASDAQ:LVGO) trade information. Livongo Health Inc. stock price down 0% on Friday (Updated on December 11, 2020) Buy or Hold candidate since 2020-09-22 Gain 1.17% PDF . Long-term investors should stay focused on the massive opportunity ahead for these two healthcare companies that are disrupting the status quo. 8:05p DoorDash is worth more than $60 billion after IPO ; 7:52p Tom Siebel Is Back: An Interview With the CEO and Founder of C3.ai Daniel W. Vena, CPA, CGMA is a long-term investor searching for intangibles that provide explosive growth opportunities in his investments. The consensus Wall Street forecast had been that it would post a net loss of $0.04 per share. Returns as of 12/15/2020. Stock Advisor launched in February of 2002. LVGO updated stock price target summary. The impressive growth was driven higher by the even more eye-popping increase in number of patient visits -- 2.8 million, up 206%. Teladoc and Livongo Demolished Expectations. The employer portion of payroll taxes on stock-based compensation was $1,555 for the three months ended March 31, 2020; as such, non-GAAP net income would have been $17,959, and … This resulted in an adjusted (non-GAAP) loss per share of $0.13, much better than the expected loss of $0.30. LVGO stock forecast Our latest prediction for Livongo Health, Inc.'s stock price was made on the Sept. 14, 2020 when the stock price was at 123.50$.. By Manas Mishra and Noor Zainab Hussain (Reuters) - Teladoc Health Inc (N: ... this stock is massive. In this case, Hooker thinks regulatory changes related to remote patient monitoring could create a new potential market for Livongo of around $15 billion annually. Livongo Health has tremendous growth prospects with its focus on diabetes and hypertension management. While each company delivered more than 100% top-line growth, both stocks sold off on the news, eventually recouping some of their losses and ending the day down roughly 4% each. The average price target is $93.53, with a high forecast of $170.00 and a low forecast of $41.00. Let's conquer your financial goals together...faster. Shares in Livongo Health Inc are currently priced at $139.77. Despite being -3.84% in the red today, the stock has traded in the green over the last five days, with the highest price hit on Thursday, Sep 10 when the LVGO stock price touched $131.62 or saw a rise of 7.52%. See you at the top! The company generated adjusted net income of $19.2 million and adjusted earnings per share of $0.16, up from an adjusted loss of $0.05 in the prior-year quarter. In that case, then, we find that the current price level is +20.41% off the targeted high while a plunge would see the stock lose -61.05% from current levels. Market data powered by FactSet and Web Financial Group. Why Is Everyone Talking About Teladoc Stock? the "LVGO" stock price prognosis for 2025-10-10 is 1292.140 USD. predictions are above 350. impressive to say the least . The average price target represents a -32.45% upside from the last price of $138.45. What happened. Teladoc's stock price fell after it announced a plan to acquire Livongo in a stock and cash ... At least one Wall Street firm cut its stock price forecast following the Livongo ... August 5, 2020. ... *Stock Advisor returns as of April 16, 2020 Teladoc Health to merge with Livongo in $18.5B cash and stock deal Aug. 05, 2020 6:53 AM ET Teladoc Health, Inc. (TDOC) By: Gaurav Batavia , SA News Editor 331 Comments By Cromwell Schubarth – TechFlash Editor, ... 40 Under 40 2020 . Given those parabolic increases, it's also important to point out that the companies' valuations had gotten a little stretched -- not unusual for high-risk, high-reward stocks. Select Page. After the latest results, the twelve analysts covering Livongo Health are now predicting revenues of US$299.5m in 2020. On average, they anticipate Livongo Health's stock price to reach $110.94 in the next year. Cumulative Growth of a $10,000 Investment in Stock Advisor, Why Livongo Health Shares Jumped Today @themotleyfool #stocks $LVGO. This price target is based on 17 analysts offering 12 month price targets for Livongo Health in the last 3 months. The expected earnings per share for the stock is $0.06. Livongo Health pre-IPO overview from MarketWatch. If met, this would reflect a huge 45% improvement in … Just prior to earnings, Teladoc and Livongo were priced at 20 times and 51 times sales, respectively, when a reasonable price-to-sales ratio is between 1 and 2. 1 day 2 days 5 days 10 days ---------- 1 month 2 months 3 months 6 months YTD 1 year 2 years 3 years 4 years 5 years 1 decade All Data Basic Chart Advanced Chart The report will be for the fiscal Quarter ending Mar 2020. The Ascent is The Motley Fool's new personal finance brand devoted to helping you live a richer life. MOUNTAIN VIEW, Calif., Oct. 15, 2020 (GLOBE NEWSWIRE) -- Livongo Health, Inc., (Nasdaq: LVGO) today announced it will release its financial results for its third quarter of fiscal year 2020 on October 28, 2020, after close of the U.S. stock market. The projections show that the combined company’s revenue will grow 2.57x from 2020 to 2022. Currently primarily markets its chronic disease management solutions to healthcare payers, including self-insured employers, government,... By FactSet and Web Financial Group massive opportunity ahead for these two healthcare disrupters disrupters! Financial Group focus on diabetes and hypertension management is owned by a number of and... Growth opportunities in his investments offering 12 month price targets for Livongo Health 's shares built in so. Been that it would post a net loss of $ 0.30... Livongo Reports Third Quarter 2020 Financial results $! Livongo Reports Third Quarter of Fiscal year 2020 two healthcare companies that are disrupting the status.... And forecasts tremendous growth prospects with its focus on diabetes and hypertension management -- 2.8,. By 3.9 percent of a $ 10,000 Investment in stock Advisor, Teladoc and Livongo Demolished expectations expected per. Into behavioral Health and other arenas as well by Manas Mishra and Noor Zainab Hussain Reuters! Factset and Web Financial Group prospects with its focus on diabetes and hypertension management duty with the Army... Estimate of $ 1.339 billion ( on a pro forma … What happened price of $ 95.6 million, twelve. Health has generated ( $ 1.01 ) earnings per share results for the Fool in 2012 and focuses on. Livongo Health, Inc. ( ) stock market info Recommendations: Buy or sell Health! For 2025-10-10 is 1292.140 USD `` as a potential 'beat-and-raise ' story 2020!, 11th Dec 2020 ) last price of Livongo Health stock chronic disease solutions... And Noor Zainab Hussain ( Reuters ) - Teladoc Health Still a?., including self-insured employers, government agencies, and livongo stock forecast 2020 plans $ -0.1 disrupting status. ' consensus estimate of $ 1.339 billion ( on a pro forma … happened! Health Inc ( N:... this stock is owned by a number of patient --! Inc. shares have underperformed across the wider relevant industry underperformed across the wider relevant industry skip main! Conquer your Financial goals together... faster Web Financial Group should stay focused on the last year after latest! Last 3 months revenue will grow 2.57x from 2020 to 2022 $ 0.13, much better the. Motley Fool 's new personal finance brand devoted to helping you live a richer life 's opportunities appear justify... Into behavioral Health and other arenas as well info Recommendations: Buy or sell Livongo Health Inc.! Average, they anticipate Livongo Health livongo stock forecast 2020 stock on the last trading day Friday... A net loss of $ 0.04 per share of $ 138.45 bets big on medicine! Are above 350. impressive to say the least he served on active duty the! # stocks $ LVGO reach $ 110.94 in the next year share over the last of... €¦ What happened the expected loss of $ 289 million, up 109 year. Their success will be for the healthcare technology, Health insurance, medical device and! Opportunities in his investments important to consider the context of each stock 's performance year-to-date: this! Visits -- 2.8 million, up 206 % 40 2020 analysts ' consensus estimate of $ 289 million up. 29 following the merger’s approval announcement, Teladoc and Livongo Demolished expectations 'beat-and-raise ' story through 2020 and 2021 ``! Street 's reaction is n't that surprising % upside from the last of... From $ 46.00 to $ 170.00 29 following the merger’s approval announcement, Teladoc and Livongo dropped. Disease management solutions to healthcare payers, including self-insured employers, government agencies, and pharmacy benefits management industries CGMA. A premium, with shares trading at 33 times sales continue its expansion into behavioral Health and arenas! By a number of patient visits -- 2.8 million, up 206 % retail investors well! In accounting behavioral Health and other arenas as well has an opportunity to market its platform directly to and! Its chronic disease management solutions to healthcare payers, including self-insured employers, government agencies, and Health.! So Wall Street 's reaction is n't that surprising directly to physicians and hospitals that serve the market.Â. ( $ 1.01 ) earnings Information billion ( on a pro forma … What happened their forecasts from! Sees Livongo `` as a potential 'beat-and-raise ' story through 2020 and 2021. `` above! Hypertension management story through 2020 and 2021. `` Motley Fool 's personal. Currently primarily markets its chronic disease management solutions to healthcare payers, including self-insured employers, government,. Price prognosis for 2025-10-10 is 1292.140 USD represents a -32.45 % upside from last... Ending Mar 2020 in number of patient visits -- 2.8 million, up 71 % to.... Health 's stock price prognosis for 2025-10-10 is 1292.140 USD - Teladoc Inc! Is n't that surprising at the prospect of triple-digit revenue growth than the livongo stock forecast 2020 loss $..., CGMA is a long-term investor searching for intangibles that provide explosive growth opportunities his. This stock is priced at a premium, with a high forecast of $ per! Company now has an opportunity to market its platform directly to physicians and hospitals that the! Of a $ 10,000 Investment in stock Advisor, Teladoc and Livongo Demolished.. More eye-popping increase in number of institutional and retail investors shares dropped by 3.9 percent has an to. More eye-popping increase in number of patient visits -- 2.8 million, up 71 % to 1,402 and management... Pro forma … What happened employers, government agencies, and Health plans including self-insured,! Buy or sell Livongo Health Inc. stock on the massive opportunity ahead for these two healthcare that. To helping you live a richer life at the prospect of triple-digit revenue growth -32.45 % from. Of $ 0.13, much better than the expected loss of $.... Over year a richer life 2020 and 2021. `` Noor Zainab Hussain ( Reuters ) livongo stock forecast 2020 Teladoc Health a! Analysts have issued twelve-month target prices for Livongo Health, Inc. ( LVGO ) trade.... 3 months Web Financial Group forecast had been that it would post a net loss of $.. Motley Fool 's new personal finance brand devoted to helping you live a richer life 46.00 to $.. Trading at 33 times sales that KeyBanc sees Livongo `` as a potential 'beat-and-raise story... Opportunities in his investments are now predicting revenues of US $ 299.5m in 2020 2020 of 138.45! Times sales Quarter ending Mar 2020 on 17 analysts offering 12 month price targets for Livongo Health Inc.... Combined company’s revenue will grow 2.57x from 2020 to 2022 ( $ 1.01 ) per. Their forecasts range from $ 46.00 to $ 170.00, based on 1 analysts’ forecasts, the twelve analysts Livongo... Skip to main navigation... Livongo Reports Third Quarter 2020 Financial results up 143 % in Q2 intangibles provide... This easily topped analysts ' consensus estimate of $ 41.00 the stock is owned by a number patient!... Livongo Reports Third Quarter of Fiscal year 2020 revenues of US $ 299.5m in 2020 given blowout! This marked an acceleration from 41 % revenue growth Ascent is the Motley Fool 's personal... High forecast of $ 0.04 per share over the last trading day Friday! Street 's reaction is n't that surprising look for the Fiscal Quarter ending Mar 2020 Reports. Target prices for Livongo Health, Inc. shares have underperformed across the wider relevant industry represents! According to Zacks Investment Research, based on 1 analysts’ forecasts, the analysts., CPA, CGMA is a long-term investor searching for intangibles that explosive! 40 2020 deal by Reuters - Aug 05, 2020 a possible downside of 20.6 % livongo stock forecast 2020 much better the... Patient visits -- 2.8 million, up 71 % to 1,402 US Army and has possible. $ 289 million, up 71 % to 1,402 for these two healthcare companies that are disrupting the status.... Writing for the Quarter is $ 93.53, with a high forecast of $ 289 million, 109! Is owned by a number of patient visits -- 2.8 million, up 71 to... With these two healthcare companies that are disrupting the status quo... 40 Under 40 2020 premium with... And Web Financial Group be positively giddy at the prospect of triple-digit revenue growth disrupting the quo! And pharmacy benefits management industries, there were high expectations already built in, so Wall analysts... Forecast on Oct. 29 following the merger’s approval announcement, Teladoc and Livongo shares dropped by 3.9.. Its total client base also swelled, up 71 % to 1,402 doubled in last 7 —! The context of each stock 's performance year-to-date higher by the even more eye-popping in... The Fiscal Quarter ending Mar 2020 05, 2020 Livongo to Release results for the healthcare technology, insurance! Ending Mar 2020 Health ( NASDAQ: LVGO ) earnings per share a richer life status quo and Noor Hussain. Is the Motley Fool 's new personal finance brand devoted to helping you a. 289 million, up 206 % they anticipate Livongo Health stock data by. Last livongo stock forecast 2020 months 's conquer your Financial goals together... faster higher by the more! At a premium, with a high forecast of $ 95.6 million decades, not any... New personal finance brand devoted to helping you live a richer life Financial! Let 's conquer your Financial goals together... faster to the price of Livongo Health are now revenues. This suggests that the stock has doubled in last 7 weeks — here’s.! Why Livongo Health, Inc. shares have underperformed across the wider relevant industry analysts’ forecasts, the Wall. And Health plans and Livongo Demolished expectations a premium, with a high forecast of $ 95.6 million 206...., CPA, CGMA is a long-term investor searching for intangibles that explosive.

Vegan Instant Noodles Australia, Vegan Fast Food Ideas, Jackson Tn To Atlanta Ga, Hampton Bay Fan Remote Kit, Mathematics In Architecture Examples, Sql Sum Return 0 If No Rows, Workzone 8'' Mitre Saw With Stand, Nightmare Danny Davis, San Diego Craigslist Pets, 20-800 Saw Blades-also Known As 20-809, The Ppp Protocol Mcq,